4//SEC Filing
Henrich Jill 4
Accession 0001140361-23-040559
CIK 0001604464other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 6:25 PM ET
Size
6.4 KB
Accession
0001140361-23-040559
Insider Transaction Report
Form 4
Henrich Jill
EVP, Chief Regulatory Officer
Transactions
- Sale
Common Stock
2023-08-16$1.65/sh−558$923→ 107,691 total - Sale
Common Stock
2023-08-16$1.65/sh−2,788$4,609→ 108,249 total
Footnotes (2)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 and August 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001978096
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 6:25 PM ET
- Size
- 6.4 KB